GJD3 Human Pre-designed siRNA Set A contains three designed siRNAs for GJD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GK Human Pre-designed siRNA Set A contains three designed siRNAs for GK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GK2 Human Pre-designed siRNA Set A contains three designed siRNAs for GK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GK5 Human Pre-designed siRNA Set A contains three designed siRNAs for GK5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GKAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for GKAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GKN1 Human Pre-designed siRNA Set A contains three designed siRNAs for GKN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GKN2 Human Pre-designed siRNA Set A contains three designed siRNAs for GKN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLA Human Pre-designed siRNA Set A contains three designed siRNAs for GLA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLB1 Human Pre-designed siRNA Set A contains three designed siRNAs for GLB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLB1L2 Human Pre-designed siRNA Set A contains three designed siRNAs for GLB1L2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLCCI1 Human Pre-designed siRNA Set A contains three designed siRNAs for GLCCI1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLCE Human Pre-designed siRNA Set A contains three designed siRNAs for GLCE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLDC Human Pre-designed siRNA Set A contains three designed siRNAs for GLDC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLDN Human Pre-designed siRNA Set A contains three designed siRNAs for GLDN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLE1 Human Pre-designed siRNA Set A contains three designed siRNAs for GLE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLG1 Human Pre-designed siRNA Set A contains three designed siRNAs for GLG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLI1 Human Pre-designed siRNA Set A contains three designed siRNAs for GLI1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Gli1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Gli1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Gli1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Gli1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLI1-IN-1 (CBC-1) is a GLI-1 inhibitor with excellent water solubility and anticancer activity. GLI1-IN-1 can induce apoptosis and suppress the growth of colorectal cancer by inhibiting the Hedgehog(HH) (IC50=1.3 μM) pathway[1].

GLI2 Human Pre-designed siRNA Set A contains three designed siRNAs for GLI2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLI3 Human Pre-designed siRNA Set A contains three designed siRNAs for GLI3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLI4 Human Pre-designed siRNA Set A contains three designed siRNAs for GLI4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLIPR1 Human Pre-designed siRNA Set A contains three designed siRNAs for GLIPR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLIPR2 Human Pre-designed siRNA Set A contains three designed siRNAs for GLIPR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLIS1 Human Pre-designed siRNA Set A contains three designed siRNAs for GLIS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLIS2 Human Pre-designed siRNA Set A contains three designed siRNAs for GLIS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLIS3 Human Pre-designed siRNA Set A contains three designed siRNAs for GLIS3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLMN Human Pre-designed siRNA Set A contains three designed siRNAs for GLMN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLMP Human Pre-designed siRNA Set A contains three designed siRNAs for GLMP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLO1 Human Pre-designed siRNA Set A contains three designed siRNAs for GLO1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Glo1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Glo1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Glo1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Glo1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLOD4 Human Pre-designed siRNA Set A contains three designed siRNAs for GLOD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLOD5 Human Pre-designed siRNA Set A contains three designed siRNAs for GLOD5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLP-1R agonist 18 (example 117) is an agonist for GLP-1R with an EC50 of 0.044 nM[1].

GLP-1R agonist 20 (Compound I-132) is an agonist for glucagon-like peptide-1 receptor (GLP-1 receptor), with EC50 of 0.0162 nM[1].

GLP-1R agonist 21 (Compound I-134) is an agonist for glucagon-like peptide-1 receptor (GLP-1 receptor), with EC50 of 0.0104 nM[1].

GLP-1R agonist 22 (Compound I-135) is an agonist for glucagon-like peptide-1 receptor (GLP-1 receptor), with EC50 of 0.0165 nM[1].

GLP1R Human Pre-designed siRNA Set A contains three designed siRNAs for GLP1R gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLP2R Human Pre-designed siRNA Set A contains three designed siRNAs for GLP2R gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLPG2737 is a potent CFTR type 2 corrector, and GLPG2737 can be used in combination with a type 1 co-corrector in the study of cystic fibrosis[1].

GLRA1 Human Pre-designed siRNA Set A contains three designed siRNAs for GLRA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLRA2 Human Pre-designed siRNA Set A contains three designed siRNAs for GLRA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLRA3 Human Pre-designed siRNA Set A contains three designed siRNAs for GLRA3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLRB Human Pre-designed siRNA Set A contains three designed siRNAs for GLRB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.